Notice of Correction to Specific Areas of Research Interest of Participating Institutes and Centers In RFA-HL-23-006, "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"
Notice Number:
NOT-HL-22-009

Key Dates

Release Date:

February 4, 2022

Related Announcements

NOT-HL-22-013 - Notice of Correction to Eligibility and Application Types in RFA-HL-23-006, " Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"

RFA-HL-23-006 - Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)

NOT-HL-22-008 - Notice of Correction to Eligibility Information in RFA-HL-23-006 "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

On January 18, 2022, the National Heart, Lung and Blood Institute (NHLBI) issued Funding Opportunity Announcement (FOA) RFA-HL-23-006, "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)". The purpose of this Notice is to inform the applicant community of a correction to Specific Areas of Research Interests for the National Institute on Aging (NIA).

The following section of RFA-HL-23-006 has been modified:

Currently Reads:

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Specific Areas of Research Interest of Participating Institutes and Centers

The National Institute on Aging supports research to advance our understanding of the nature of aging and the aging process, as well as diseases and conditions associated with growing older, in order to extend the healthy, active years of life. NIA’s Division of Aging Biology supports molecular, cellular, and genetic research on the mechanisms of aging. The Division of Behavioral and Social Research supports social, behavioral, and economic research on the processes of aging at both the individual and societal level, including cross-disciplinary research, at multiple levels from genetics to cross-national comparative research, and at stages from basic through translational. The Division of Geriatrics and Clinical Gerontology supports clinical and translational research on health and disease in the aged, and research on aging over the human lifespan, including its relationships to health outcomes, with foci that include translational research for the development of new interventions for age-related conditions, prevention and treatment of multiple chronic conditions in the elderly, and studies that help to promote evidence-based geriatric care and inform policies affecting older adults. The Division of Neuroscience supports collaborative research to further the understanding of neural and behavioral processes associated with the aging brain. Research on dementias of old age—in particular Alzheimer’s Disease and Related Dementias (ADRD) disease—is one of the program’s highest priorities. Note: The NIA will support only investigators in clinical fellowship under this FOA. Investigators interested in research support as early career faculty are encouraged to consider NIA's GEMSSTAR program.

Modified to Read:

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Specific Areas of Research Interest of Participating Institutes and Centers

The National Institute on Aging supports research to advance our understanding of the nature of aging and the aging process, as well as diseases and conditions associated with growing older, in order to extend the healthy, active years of life. NIA’s Division of Aging Biology supports molecular, cellular, and genetic research on the mechanisms of aging. The Division of Behavioral and Social Research supports social, behavioral, and economic research on the processes of aging at both the individual and societal level, including cross-disciplinary research, at multiple levels from genetics to cross-national comparative research, and at stages from basic through translational. The Division of Geriatrics and Clinical Gerontology supports clinical and translational research on health and disease in the aged, and research on aging over the human lifespan, including its relationships to health outcomes, with foci that include translational research for the development of new interventions for age-related conditions, prevention and treatment of multiple chronic conditions in the elderly, and studies that help to promote evidence-based geriatric care and inform policies affecting older adults. The Division of Neuroscience supports collaborative research to further the understanding of neural and behavioral processes associated with the aging brain. Research on dementias of old age—in particular Alzheimer’s Disease and Related Dementias (ADRD) disease—is one of the program’s highest priorities.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries regarding this Notice to:

Scientific/Research Contact

David Schopfer, M.D.
National Heart Lung and Blood Institute (NHLBI)
Telephone: 301-402-3833
Email: david.schopfer@nih.gov